Ethnic and racial disparities in cervical cancer: lessons from a modelling study of cervical cancer prevention
Menée à l'aide d'une modélisation, cette étude estime en Angleterre, en fonction de l'appartenance ethnique, l'effet de programmes de vaccination contre le papillomavirus humain et de programmes de dépistage du cancer du col de l'utérus sur l'incidence de la maladie
Cervical cancer, a preventable disease, still affects more than 500 000 women and kills close to 300 000 women globally every year.1 It is now more than a decade since the advent of HPV vaccines, yet millions of women are beyond the recommended age of vaccination, and if cervical screening rates do not dramatically increase, an estimated 19 million will die of cervical cancer in the next 40 years.2 While most cervical cancer cases and deaths occur in low-income and middle-income countries, every country should be asking a few important questions: How are we doing towards reaching the goal of cervical cancer elimination?3 Have we reached our projected targets for population coverage of HPV vaccination and cervical cancer screening? And, crucially, where are the gaps—the key differences in access, utilisation, and in the (short term) measurable health effects such as cervical dysplasia and invasive cervical cancer between the general population and the many underserved population groups that bear the disproportionate burden of this cancer?
The Lancet Public Health , commentaire en libre accès, 2017